The post-mastectomy syndrome: the secondary lympedema after the combined treatment of breast cancer (the literature review and own results)

Cover Page

Cite item

Full Text

Abstract

The post-mastectomy syndrome and lymphedema after the combined treatment of breast cancer, significantly worsen the quality of life of patients, their psycho - emotional state. The treatment of this disease is always combined in nature, and involves elements of the Complex Decongestive Therapy, pneumatic compression, mild electrical stimulation and low-frequency magnetic therapy. The best results of therapy are achieved with early detection and treatment. Complex treatment of lymphedema does not affect the course of cancer.

About the authors

A M Stepanova

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

Email: stepanovas@list.ru
канд. мед. наук, зав. отд-нием реабилитации 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

A M Merzlyakova

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

канд. мед. наук, врач-онколог отд-ния реабилитации 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

M M Khulamhanova

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation

врач-физиотерапевт отд-ния реабилитации 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

O P Trofimova

N.N.Blokhin National Medical Research Center of Oncology of the Ministry of Health of the Russian Federation; Russian Medical Academy of Continuous Professional Education of the Ministry of Health of the Russian Federation

д-р мед. наук, вед. науч. сотр. радиологического отд-ния, проф. каф. онкологии 115478, Russian Federation, Moscow, Kashirskoe sh., d. 23

References

  1. Hill D.A, Horick N.K, Isaacs C et al. Long-term risk of medical conditions associated with breast cancer treatment. Breast Cancer Res Treat 2014; 145 (1): 233-43.
  2. Hayes S, Di Sipio T, Rye S et al. Prevalence and prognostic significance of secondary lymphedema following breast cancer. Lymphat Res Biol 2011; 9 (3): 135-41.
  3. Ashikaga T, Krag D.N, Land S.R et al. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection. J Surg Oncol 2010; 102 (2): 111-8.
  4. Chachaj A, Malyszczak K, Pyszel K et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 2009; 19 (3): 299-305.
  5. Ткаченко Г.А. Психологическая помощь на этапах реабилитации больных раком молочной железы. В кн.: Материалы Петербургского онкологического форума «Белые ночи-2017». СПб., 2017; с. 42-3.
  6. Тишакова В.Э., Филоненко Е.В., Чиссов В.И. и др. Физические методы реабилитации онкологических больных после комбинированного лечения рака молочной железы. Biomedical Photonics. 2017; 6 (1): 28-37
  7. Shih Y.C, Xu Y, Cormier J.N et al. Incidence, treatment costs, and complications of lymphedema after breast cancer among women of working age: a 2-year follow-up study. J Clin Oncol 2009; 27 (12): 2007-14.
  8. Pereira R A.C.P, Koifman R.J, Bergmann A. Incidence and risk factors of lymphedema after breast cancer treatment: 10 years of follow-up. Breast 2017; 36: 67-73.
  9. Ozcinar B, Guler S.A, Kocaman N et al. Breast cancer related lymphedema in patients with different loco-regional treatments. Breast 2012; 21 (3): 361-5.
  10. Ohsumi S, Shimozuma K, Ohashi Y et al. Subjective and objective assessment of edema during adjuvant chemotherapy for breast cancer using taxane-containing regimens in a randomized controlled trial: The National Surgical Adjuvant Study of Breast Cancer 02. Oncology 2012; 82 (3): 131-8.
  11. Hidding J.T, Beurskens C.H.G, van der Wees P.J et al. Changes in volume and incidence of lymphedema during and after treatment with docetaxel, doxorubicin, and cyclophosphamide (TAC) in patients with breast cancer. Support Care Cancer 2018; 26 (5): 1383-92.
  12. Ridner S.H, Dietrich M.S, Stewart B.R, Armer J.M. Body mass index and breast cancer treatment-related lymphedema. Support Care Cancer 2011; 19 (6): 853-7.
  13. National Lymphedema Network. Supplement to National Lymphedema Network Position Statement Breast Cancer Screening. Screening and Early Detection of Breast Cancer-Related Lymphedema: The Imperative. http://www.lymphnet.org/pdfDocs/PP_Lymphedema_ BC_Supplement.pdf
  14. Yamada S, Yamada Y, Kobayashi M et al. Post-mastectomy benign lymphangioendothelioma of the skin following chronic lymphedema for breast carcinoma: a teaching case mimicking low-grade angiosarcoma and masquerading as Stewart-Treves syndrome. Diagn Pathol 2014; 9 (1): 197.
  15. Agbenorku P. Lymphedema: Complications and Management. Surg Sci 2014; 5: 290-8.
  16. Vignes S. Lymphedema: From diagnosis to treatment. Rev Med Interne 2017; 38 (2): 97-105.
  17. McLaughlin S.A et al. Considerations for Clinicians in the Diagnosis, Prevention, and Treatment of Breast Cancer-Related Lymphedema: Recommendations from a Multidisciplinary Expert ASBrS Panel. Part 1: Definitions, Assessments, Education and Future Directions. Part 2: Preventive and Therapeutic Options. Ann Surg Oncol 2017; 24: 2818-35.
  18. Adams K.E, Rasmussen J.C, Darne C et al. Direct evidence of lymphatic function improvement after advanced pneumatic compression device treatment of lymphedema. Biomed Opt Express 2010; 1 (1): 114-25.
  19. Devoogdt N, Van Kampen M, Geraerts I et al. Different physical treatment modalities for lymphoedema developing after axillary lymph node dissection for breast cancer: a review. Eur J Obstet Gynecol Reprod Biol 2010; 149 (1): 3-9.
  20. Boris M, Weindorf S, Lasinski B.B. The risk of genital edema after external pump compression for lower limb lymphedema. Lymphology 1998; 31 (1): 15-20.
  21. Karaca-Mandic P, Hirsch A.T, Rockson S.G, Ridner S.H. The Cutaneous, Net Clinical, and Health Economic Benefits of Advanced Pneumatic Compression Devices in Patients With Lymphedema. JAMA Dermatol 2015; 151 (11): 1187-93.
  22. Dirican A, Andacoglu O, Johnson R et al. The short-term effects of low-level laser therapy in the management of breast-cancerrelated lymphedema. Support Care Cancer 2011; 19 (5): 685-90.
  23. Грушина Т.И. Реабилитация в онкологии: физиотерапия. М.: ГЭОТАР-Медиа, 2006
  24. Lievens P.C. The effect of combined HeNe and I.R. laser treatment on the regeneration of the lymphatic system during the process of wound healing. Lasers Med Sci 1991; 6 (2): 193-9.
  25. Monteiro S.E, Resende L.V, Felicíssimo M.F et al. Fisioter Mov 2014; 27 (4): 663-74.
  26. Baxter G.D, Liu L, Petrich S et al. Low level laser therapy (Photobiomodulation therapy) for breast cancer-related lymphedema: a systematic review. BMC Cancer 2017; 17: 833.
  27. Weissleder H, Schuchhardt C. Anatomy (fundamentals). In: Lymphoedema Diagnosis and Treatment. Wesel, Baden-Baden, 2008.
  28. Havas E, Lehtonen M, Vuorela J et al. Albumin clearance from human skeletal muscle during prolonged steady-state running. Exp Physiol 2000; 85 (6): 863-8.
  29. Piller N, Douglass J, Heidenreich B, Moseley А. Placebo controlled trial of mild electrical stimulation. J Lymphoedema 2010; 5 (1).
  30. Грушина Т.И. Какой метод физиотерапии постмастэктомической лимфедемы наиболее эффективен? Вопр. курортологии, физиотерапии и лечеб. физ. культуры. 2017; 94 (4): 59-66.
  31. Wilburn O, Wilburn P, Rockson S.G. A pilot, prospective evaluation of a novel alternative for maintenance therapy of breast cancer-associated lymphedema. BMC Cancer 2006; 6: 84.
  32. Герасименко М.Ю., Князева Т.А., Апханова Т.В., Кульчицкая Д.Б. Применение метода кинезиотейпирования в немедикаментозной комплексной реабилитации больных лимфедемой нижних конечностей. Вопр. курортологии, физиотерапии и лечеб. физ. культуры. 2015; 92 (5): 22-7.
  33. Smykla A, Walewicz K, Trybulski T et al. Effect of Kinesiology Taping on Breast Cancer-Related Lymphedema: A Randomized Single-Blind Controlled Pilot Study. BioMed Research Int 2013; ID 767106: 7.
  34. Mestre S, Calais, C, Gaillard G et al. Interest of an auto-adjustable nighttime compression sleeve (MOBIDERM Autofit) in maintenance phase of upper limb lymphedema: the MARILYN pilot RCT. Support Care Cancer 2017; 25: 2455.

Copyright (c) 2018 Consilium Medicum

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies